|
Volumn 39, Issue 3-4, 2005, Pages 791-795
|
Determination of atazanavir in human plasma using solid-phase extraction and high-performance liquid chromatography
|
Author keywords
Atazanavir; Protease inhibitors; Reversed phase chromatography; Solid phase extraction; Therapeutic drug monitoring
|
Indexed keywords
ABACAVIR;
AMPHOTERICIN B;
AMPRENAVIR;
ATAZANAVIR;
BROMAZEPAM;
DIAZEPAM;
DIDANOSINE;
EFAVIRENZ;
ETHAMBUTOL;
FLUCONAZOLE;
FLUCYTOSINE;
FLUOXETINE;
FLUVOXAMINE;
INDINAVIR;
ISONIAZID;
ITRACONAZOLE;
LAMIVUDINE;
LOPINAVIR;
METHADONE;
NELFINAVIR;
NEVIRAPINE;
NORDAZEPAM;
OXAZEPAM;
PRAZEPAM;
PYRAZINAMIDE;
RIFAMPICIN;
RITONAVIR;
SAQUINAVIR;
SULFAMETHOXAZOLE;
UNINDEXED DRUG;
ACCURACY;
ARTICLE;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
DRUG DETERMINATION;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
PLASMA;
PRIORITY JOURNAL;
SOLID PHASE EXTRACTION;
ULTRAVIOLET RADIATION;
VALIDATION PROCESS;
ACETONITRILES;
CALIBRATION;
CARBON;
CHROMATOGRAPHY;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG MONITORING;
DRUG STABILITY;
HIV PROTEASE INHIBITORS;
HUMANS;
OLIGOPEPTIDES;
PYRIDINES;
QUALITY CONTROL;
REPRODUCIBILITY OF RESULTS;
SENSITIVITY AND SPECIFICITY;
SPECTROPHOTOMETRY, ULTRAVIOLET;
ULTRAVIOLET RAYS;
|
EID: 23944456150
PISSN: 07317085
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jpba.2005.04.025 Document Type: Article |
Times cited : (26)
|
References (10)
|